Results 241 to 250 of about 166,146,473 (295)

Mechanobiological feedback loops and quantitative decision thresholds in organ fibrosis: Translational principles for antifibrotic therapy. [PDF]

J Cell Commun Signal
Lonardo A, Weiskirchen R.
europepmc   +1 more source

SASP-mediated cellular senescence following myocardial infarction: from spatiotemporal immune regulation to therapeutic strategies. [PDF]

Front Immunol
Zhang F, Liao Y, Yang P, Guo J.
europepmc   +1 more source

Myocardial Fibrosis in Cardiovascular Disease: An Integrative Biomarker-Imaging Framework Linking Molecular Mechanisms to Structural Phenotypes. [PDF]

J Clin Med
Świątko M, Baran JM, Czernicka A, Dudek Ł, Szewczyk M, Pietruszka J, Łazarowicz Ł, Kochman W, Dziedzic EA.   +8 more
europepmc   +1 more source

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas

, 1996
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human subconjunctival tissues

Current Eye Research, 1998
To evaluate the roles of fibroblast proteins in the remodeling of the subconjunctival connective tissue, we immunohistochemically assessed the expression of matrix metalloproteinases (MMP)-1 and -2, and the tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2 in cultured human subconjunctival fibroblasts and in normal and healing human ...
Yoshitaka Ohnishi, Osamu Yamanaka, O Yamanaka   +2 more
exaly   +3 more sources

Dysregulation of Matrix Metalloproteinases and their Tissue Inhibitors by S100A4

Connective Tissue Research, 2008
The S100A4 protein as well as the matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are associated with diseases such as arthritis and cancer. This mini review focuses on in vitro and in vivo studies indicating S100A4 involvement in regulation of MMPs and TIMPs, and the biological and pathobiological consequences of this regulation.
Renate, Elenjord, Hilde, Ljones, Elisabeth, Sundkvist, Thrina, Loennechen, Jan Olof, Winberg   +4 more
exaly   +3 more sources

Tissue inhibitors of matrix metalloproteinases in cancer.

Annals of the New York Academy of Sciences, 1999
Tissue inhibitors of metalloproteinases (TIMPs) play a key regulatory role in the homeostasis of the extracellular matrix (ECM) by controlling the activity of matrix metalloproteinases (MMPs). Some TIMPs have a second function as well, unrelated to their antiMMP activity, which affects cell proliferation and survival.
L, Blavier, P, Henriet, S, Imren, Y A, Declerck   +3 more
openaire   +2 more sources

Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease

2021
Matrix metalloproteinases (MMPs) are a group of zinc and calcium endopeptidases which cleave extracellular matrix (ECM) proteins. They are also involved in the degradation of cell surface components and regulate multiple cellular processes, cell to cell interactions, cell proliferation, and cell signaling pathways.
Oskar, Zakiyanov, Marta, Kalousová, Tomáš, Zima, Vladimír, Tesař   +3 more
openaire   +2 more sources